Repare Therapeutics Inc. (Nasdaq: RPTX), a clinical-stage precision oncology company, announced a strategic shift to prioritize the development of its clinical-stage oncology programs. The company will concentrate on advancing its…
Fresenius Kabi has introduced Cetrorelix Acetate for Injection, an FDA-approved, cost-effective generic option for women’s reproductive health. The kit, available immediately, includes one single-dose vial of 0.25 mg cetrorelix, a…
BioAesthetics Corporation has appointed Dr. Juliana Blum, PhD, as its new Chief Executive Officer, starting August 12, 2024. Dr. Sandra Coufal, MD, Director of BioAesthetics and CEO of Toragen, Inc.,…
Qventus, a leader in AI-driven care operations software, has introduced the industry’s first AI Operational Assistants. These innovative digital assistants are designed to help frontline staff focus on their core…
ImmunoPrecise Antibodies Ltd. (IPA) (NASDAQ: IPA) is excited to announce its participation in the 26th Annual HC Wainwright Global Investment Conference. The conference, held in-person at the Lotte New York…
Cardinal Health recently unveiled its new Advanced Therapy Innovation Center in La Vergne, Tennessee. This 8,000 square-foot facility, housed within a 172,000 square-foot Cardinal Health distribution center, is designed to…
eClinicalWorks®, the leading provider of cloud-based EHR systems, has announced that Creekside Family Practice is effectively using eClinicalWorks EHR and healow® Open Access® for online appointment scheduling. The practice has…
Forge Health, a top provider of outpatient mental health and substance use care, has secured a strategic growth investment from MFO Ventures. This funding will support the optimization and expansion…
ADVI Health is excited to announce the acquisition of Partnership for Health Analytic Research (PHAR), a leading global consultancy specializing in health technology assessment (HTA) and health economics and outcomes…
Invenra Inc. is excited to announce that its innovative bispecific antibody, INV724, designed for the treatment of neuroblastoma, has received both Rare Pediatric Disease (RPDD) and Orphan Drug (ODD) Designations…
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Carilion Clinic, a nonprofit healthcare provider serving over one million people in Virginia and West Virginia, have…
Actio Biosciences, a biotechnology firm focused on utilizing a novel genetic and precision medicine platform to create therapeutics for both rare and common diseases, has appointed Dr. Dimitrios Arkilo as…